hero image
Follow us!

Insurance companies sometimes try to save money by increasing patients’ out-of-pocket costs for drugs, moving prescriptions to a more restrictive tier, or removing prescriptions from the formulary altogether.

President Trump renewed his attack on drug manufacturers last week, tweeting, “Pfizer & others should be ashamed that they have raised drug prices for no reason.

In the debate over prescription drug prices, one group is being overlooked: people with rare diseases. The needs of these patients, who rely on specialty medications for their lives and livelihoods, must not be sacrificed in the quest to bring down drug costs. 

How can President Trump and Health and Human Services Secretary Alex Azar deliver on their new “American Patients First” plan to reduce prescription drug costs?